While low fluid infusion leads to better clinical outcomes, it is also associated with higher mortality. Currently available data did not clearly support a specific fluid infusion resuscitation volume ...

Endoscopic cuffitis occurs in approximately 60% of patients with UC who undergo RPC and IPAA. Among patients with ulcerative colitis (UC) who had restorative proctocolectomy (RPC) with stapled ileal ...

Decreasing sitting time by more than 30 minutes in older adults can reduce systolic blood pressure. Systolic blood pressure in older adults can be reduced by decreasing daily sitting time by more than ...

There is increased risk for gestational diabetes mellitus in patients with history of spontaneous abortion. Patients who have a history of spontaneous abortion (SAB) have an increased risk of ...

Lower extremity amputation risk was lower among users of SGLT-2 inhibitors vs DPP-4 inhibitors but higher among users of SGLT-2 inhibitors vs sulfonylureas. Among patients with type 2 diabetes, sodium ...

Individuals with type 2 diabetes who have received insulin treatment may have an increased risk for advanced adenomas. Insulin therapy is associated with an increased risk for advanced colorectal ...

CTX-009 is a bispecific antibody that simultaneously blocks Delta-like ligand 4 and vascular endothelial growth factor A. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Clinicians should consider the multifactorial aspects of deciding whether an older adult with dementia should undergo colonoscopy. While older adults with dementia do not demonstrate increased ...

In the general population, 8-hour time-restricted eating significantly increases risk of cardiovascular mortality. A daily 8-hour time-restricted eating (TRE) plan is associated with a significantly ...

Researchers identified 46 accelerated approvals of cancer drugs with at least 5 years of follow-up data and found that, for 57% of these approvals, the drugs did not provide improvements in overall ...

The FDA is expected to make decisions about 2 therapies for 3 oncology indications next month. The US Food and Drug Administration (FDA) is expected to decide whether to approve rivoceranib in ...

While patients with diverticular disease have an increased risk for extraintestinal cancers, they have a decreased risk for colorectal cancer possibly due to undergoing colonoscopy and polypectomy ...